Outlook Therapeutics EPS Diluted from Extraordinaries (Quarterly) Analysis

Outlook Therapeutics, Inc. (OTLK)

0.4131 -0.02 (-4.95%) USD | NASDAQ | Feb 20, 16:00

0.41 0.00 (0.00%) After-Hours: 20:00

View EPS Diluted from Extraordinaries (Quarterly) for OTLK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

Ironwood Pharmaceuticals, Inc.	--
Amicus Therapeutics, Inc.	--
Neogen Corp.	--
CorMedix, Inc.	--
ACADIA Pharmaceuticals, Inc.	--